<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35015778</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Comparison of longitudinal trends in self-reported symptoms and COVID-19 case activity in Ontario, Canada.</ArticleTitle><Pagination><StartPage>e0262447</StartPage><MedlinePgn>e0262447</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0262447</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0262447</ELocationID><Abstract><AbstractText Label="BACKGROUND">Limitations in laboratory diagnostic capacity impact population surveillance of COVID-19. It is currently unknown whether participatory surveillance tools for COVID-19 correspond to government-reported case trends longitudinally and if it can be used as an adjunct to laboratory testing. The primary objective of this study was to determine whether self-reported COVID-19-like illness reflected laboratory-confirmed COVID-19 case trends in Ontario Canada.</AbstractText><AbstractText Label="METHODS">We retrospectively analyzed longitudinal self-reported symptoms data collected using an online tool-Outbreaks Near Me (ONM)-from April 20th, 2020, to March 7th, 2021 in Ontario, Canada. We measured the correlation between COVID-like illness among respondents and the weekly number of PCR-confirmed COVID-19 cases and provincial test positivity. We explored contemporaneous changes in other respiratory viruses, as well as the demographic characteristics of respondents to provide context for our findings.</AbstractText><AbstractText Label="RESULTS">Between 3,849-11,185 individuals responded to the symptom survey each week. No correlations were seen been self-reported CLI and either cases or test positivity. Strong positive correlations were seen between CLI and both cases and test positivity before a previously documented rise in rhinovirus/enterovirus in fall 2020. Compared to participatory surveillance respondents, a higher proportion of COVID-19 cases in Ontario consistently came from low-income, racialized and immigrant areas of the province- these groups were less well represented among survey respondents.</AbstractText><AbstractText Label="INTERPRETATION">Although digital surveillance systems are low-cost tools that have been useful to signal the onset of viral outbreaks, in this longitudinal comparison of self-reported COVID-like illness to Ontario COVID-19 case data we did not find this to be the case. Seasonal respiratory virus transmission and population coverage may explain this discrepancy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maharaj</LastName><ForeName>Arjuna S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-2155-7014</Identifier><AffiliationInfo><Affiliation>Doctor of Medicine Program, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2206-4120</Identifier><AffiliationInfo><Affiliation>Doctor of Medicine Program, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Jessica P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-6587-9130</Identifier><AffiliationInfo><Affiliation>Public Health Ontario, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gournis</LastName><ForeName>Effie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Toronto Public Health, City of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogoch</LastName><ForeName>Isaac I</ForeName><Initials>II</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University Health Network, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rader</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Computational Epidemiology Lab, Boston Children's Hospital, Boston, MA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Boston University, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astley</LastName><ForeName>Christina M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Computational Epidemiology Lab, Boston Children's Hospital, Boston, MA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard and MIT, Cambridge, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivers</LastName><ForeName>Noah M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Women's College Research Institute, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Jared B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Computational Epidemiology Lab, Boston Children's Hospital, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Liza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuite</LastName><ForeName>Ashleigh R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisman</LastName><ForeName>David N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brownstein</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Computational Epidemiology Lab, Boston Children's Hospital, Boston, MA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Biomedical Informatics, Harvard Medical School, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapointe-Shaw</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4485-6719</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University Health Network, Toronto, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 DK120899</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>We have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: IIB has consulted to BlueDot, a social benefit corporation that tracks the spread of emerging infectious diseases. DNF reports personal consultant fees from Pfizer, AstraZeneca, and Seqirus, outside the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>17</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35015778</ArticleId><ArticleId IdType="pmc">PMC8754059</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0262447</ArticleId><ArticleId IdType="pii">PONE-D-21-20494</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharfstein JM, Becker SJ, Mello MM. Diagnostic Testing for the Novel Coronavirus. Vol. 323, JAMA&#x2014;Journal of the American Medical Association. 2020. p. 1437&#x2013;8. doi: 10.1001/jama.2020.3864</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3864</ArticleId><ArticleId IdType="pubmed">32150622</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, et al.. Detecting 2009 pandemic influenza a (H1N1) virus infection: Availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis. 2011;52(SUPPL. 1). doi: 10.1093/cid/ciq020</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciq020</ArticleId><ArticleId IdType="pubmed">21342897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Public Heal. 2020. Aug 1;5(8):e452&#x2013;9. doi: 10.1016/S2468-2667(20)30157-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30157-2</ArticleId><ArticleId IdType="pmc">PMC7365652</ArticleId><ArticleId IdType="pubmed">32682487</ArticleId></ArticleIdList></Reference><Reference><Citation>Rader B, Astley CM, Sy KTL, Sewalk K, Hswen Y, Brownstein JS, et al.. Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates. J Travel Med. 2020;27(7). doi: 10.1093/jtm/taaa076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa076</ArticleId><ArticleId IdType="pmc">PMC7239151</ArticleId><ArticleId IdType="pubmed">32412064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapointe-Shaw L, Rader B, Astley CM, Hawkins JB, Bhatia D, Schatten WJ, et al.. Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study. PLoS One. 2020;15(10 October). doi: 10.1371/journal.pone.0239886</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239886</ArticleId><ArticleId IdType="pmc">PMC7531838</ArticleId><ArticleId IdType="pubmed">33006990</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltrusaitis K, Santillana M, Crawley AW, Chunara R, Smolinski M, Brownstein JS. Determinants of Participants&#x2019; Follow-Up and Characterization of Representativeness in Flu Near You, A Participatory Disease Surveillance System. JMIR Public Heal Surveill. 2017;3(2):e18. doi: 10.2196/publichealth.7304</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/publichealth.7304</ArticleId><ArticleId IdType="pmc">PMC5400887</ArticleId><ArticleId IdType="pubmed">28389417</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltrusaitis K, Brownstein JS, Scarpino S V., Bakota E, Crawley AW, Conidi G, et al.. Comparison of crowd-sourced, electronic health records based, and traditional health-care based influenza-tracking systems at multiple spatial resolutions in the United States of America. BMC Infect Dis. 2018;18(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6094455</ArticleId><ArticleId IdType="pubmed">30111305</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownstein JS, Chu S, Marathe A, Marathe M V, Nguyen AT, Paolotti D, et al.. Combining Participatory Influenza Surveillance with Modeling and Forecasting: Three Alternative Approaches. JMIR Public Heal Surveill. 2017;3(4):e83. doi: 10.2196/publichealth.7344</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/publichealth.7344</ArticleId><ArticleId IdType="pmc">PMC5688248</ArticleId><ArticleId IdType="pubmed">29092812</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Wijngaard C, Van Asten L, Van Pelt W, Nagelkerke NJD, Verheij R, De Neeling AJ, et al.. Validation of syndromic surveillance for respiratory pathogen activity. Emerg Infect Dis. 2008;14(6):917&#x2013;25. doi: 10.3201/eid1406.071467</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1406.071467</ArticleId><ArticleId IdType="pmc">PMC2600280</ArticleId><ArticleId IdType="pubmed">18507902</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AT, Brownstein JS. Putting the Public Back in Public Health&#x2014;Surveying Symptoms of Covid-19. N Engl J Med. 2020;383(7):e45. doi: 10.1056/NEJMp2016259</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2016259</ArticleId><ArticleId IdType="pubmed">32501663</ArticleId></ArticleIdList></Reference><Reference><Citation>Desjardins MR. Syndromic surveillance of COVID-19 using crowdsourced data. Lancet Reg Heal&#x2014;West Pacific. 2020;4:100024. doi: 10.1016/j.lanwpc.2020.100024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2020.100024</ArticleId><ArticleId IdType="pmc">PMC7563097</ArticleId><ArticleId IdType="pubmed">34013214</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneoka D, Tanoue Y, Kawashima T, Nomura S, Shi S, Eguchi A, et al.. Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo. Lancet Reg Heal&#x2014;West Pacific. 2020;3:100016. doi: 10.1016/j.lanwpc.2020.100016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2020.100016</ArticleId><ArticleId IdType="pmc">PMC7546969</ArticleId><ArticleId IdType="pubmed">34173599</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura S, Yoneoka D, Shi S, Tanoue Y, Kawashima T, Eguchi A, et al.. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency? Lancet Reg Heal&#x2014;West Pacific. 2020;1:100011. doi: 10.1016/j.lanwpc.2020.100011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2020.100011</ArticleId><ArticleId IdType="pmc">PMC7453215</ArticleId><ArticleId IdType="pubmed">34173594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessler J, Grabowski MK, Grantz KH, Badillo-goicoechea E, Metcalf CJE, Azman AS, et al.. Household COVID-19 risk and in-person schooling. 2021;2939(April):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168618</ArticleId><ArticleId IdType="pubmed">33927057</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Lie Y, Prinzen FW. Surveillance of COVID-19 in the General Population Using an Online Questionnaire: Report From 18,161 Respondents in China. JMIR public Heal Surveill [Internet]. 2020. Apr 27;6(2):e18576&#x2013;e18576. Available from: doi: 10.2196/18576</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/18576</ArticleId><ArticleId IdType="pmc">PMC7187763</ArticleId><ArticleId IdType="pubmed">32319956</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharaj AS, Parker J, Hopkins JP, Gournis E, Bogoch II, Rader B, et al.. The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada. Lancet Infect Dis. 2021. Mar. doi: 10.1016/S1473-3099(21)00151-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00151-1</ArticleId><ArticleId IdType="pmc">PMC7993926</ArticleId><ArticleId IdType="pubmed">33773620</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttmann A, Gandhi S, Wanigaratne S, Lu H, Le F-L, Gozdyra PJ, et al.. COVID-19 in Immigrants, Refugees and Other
Newcomers in Ontario: Characteristics of Those Tested and Those Confirmed
Positive, as of June 13, 2020 [Internet]. 2020.
1&#x2013;140 p. Available from: www.ices.on.ca.</Citation></Reference><Reference><Citation>ISO 8601&#x2011;1:2019. Date and time&#x2014;Representations for information interchange&#x2014;Part 1: Basic rules. ISO&#x2014;Int Organ Stand. 2019.</Citation></Reference><Reference><Citation>National
Notifiable Diseases Surveillance System. Coronavirus
Disease 2019 (COVID-19) 2020 Interim Case Definition, Approved April 5,
2020 [Internet]. Vol. 2019, Centers
for Disease Control and Prevention. 2020. p.
2019&#x2013;21. Available from: https://wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/.</Citation></Reference><Reference><Citation>Reses HE, Fajans M, Lee SH, Heilig CM, Chu VT, Thornburg NJ, et al.. Performance of existing and novel surveillance case definitions for COVID-19 in household contacts of PCR-confirmed COVID-19. BMC Public Health [Internet]. 2021;21(1):1747. Available from: doi: 10.1186/s12889-021-11683-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11683-y</ArticleId><ArticleId IdType="pmc">PMC8465785</ArticleId><ArticleId IdType="pubmed">34563163</ArticleId></ArticleIdList></Reference><Reference><Citation>Reses HE, Fajans M, Lee SH, Heilig CM, Chu VT, Thornburg NJ, et al.. Performance of Existing and Novel
Surveillance Case Definitions for COVID-19 in the Community.
medRxiv [Internet].
2020;2020.10.02.20195479. Available from:
http://medrxiv.org/content/early/2020/10/06/2020.10.02.20195479.abstract.</Citation></Reference><Reference><Citation>Statistics Canada. Census Program. 2021.</Citation></Reference><Reference><Citation>Statistics Canada. Data
products, 2016 Census [Internet]. 2016 [cited 2021 May 21]. Available from:
https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/index-eng.cfm.</Citation></Reference><Reference><Citation>Forward Sortation
Area&#x2014;Definition&#x2014;Office of the Superintendent of Bankruptcy Canada [Internet].
[cited 2021 May 30]. Available from: https://www.ic.gc.ca/eic/site/bsf-osb.nsf/eng/br03396.html.</Citation></Reference><Reference><Citation>Sudre CH, Keshet A, Graham MS, Joshi AD, Shilo S, Rossman H, et al.. Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: An observation study [Internet]. medRxiv. Cold Spring Harbor Laboratory Press; 2020. [cited 2021 Jun 21]. p. 2020.12.15.20248096. Available from: doi: 10.1101/2020.12.15.20248096</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.15.20248096</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharaj AS, Parker J, Hopkins JP, Gournis E, Bogoch II, Rader B, et al.. The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada. Lancet Infect Dis. 2021. May. doi: 10.1016/S1473-3099(21)00151-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00151-1</ArticleId><ArticleId IdType="pmc">PMC7993926</ArticleId><ArticleId IdType="pubmed">33773620</ArticleId></ArticleIdList></Reference><Reference><Citation>King JA, Whitten TA, Bakal JA, McAlister FA. Symptoms associated with a positive result for a swab
for SARS-CoV-2 infection among children in Alberta.
CMAJ [Internet]. 2021. 
Jan
4 [cited 2021 Jun
18];193(1):E1&#x2013;9.
Available from: www.cmaj.ca/lookup/doi/10.1503/cmaj.202065/tab-related-content.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.202065/tab-related-content</ArticleId><ArticleId IdType="pmc">PMC7774482</ArticleId><ArticleId IdType="pubmed">33234533</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada. Population estimates on July 1st, by age and sex (Table 17-10-0005-01) [Internet]. Statistics Canada,. 2019. [cited 2020 Aug 23]. p. 2018&#x2013;20. Available from: 10.25318/1710000501-eng.</Citation><ArticleIdList><ArticleId IdType="doi">10.25318/1710000501-eng</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Maxwell CJ, Armstrong P, Schwandt M, Moser A, McGregor MJ, et al.. COVID-19 in long-term care homes in
Ontario and British Columbia. CMAJ
[Internet]. 2020. 
Nov
23 [cited 2021 May
18];192(47):E1540&#x2013;6.
Available from: www.cmaj.ca/lookup/doi/
doi: 10.1503/cmaj.201860
</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.201860</ArticleId><ArticleId IdType="pmc">PMC7721263</ArticleId><ArticleId IdType="pubmed">32998943</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JA, Nielsen FBH, Badiani AA, Assi S, Unadkat VA, Patel B, et al.. Poverty, inequality and COVID-19: the forgotten vulnerable. Vol. 183, Public Health. 2020. p. 110&#x2013;1. doi: 10.1016/j.puhe.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7221360</ArticleId><ArticleId IdType="pubmed">32502699</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>